Takeda Pharmaceutical
313 hedge funds and large institutions have $1.09B invested in Takeda Pharmaceutical in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 117 increasing their positions, 85 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.63% less ownership
Funds ownership: 5.58% → 4.94% (-0.63%)
14% less capital invested
Capital invested by funds: $1.26B → $1.09B (-$172M)
80% less funds holding in top 10
Funds holding in top 10: 5 → 1 (-4)
Holders
313
Holding in Top 10
1
Calls
$26.1M
Puts
$1.72M
Top Buyers
| 1 | +$54.8M | |
| 2 | +$9.02M | |
| 3 | +$5.5M | |
| 4 |
VanEck Associates
New York
|
+$5.01M |
| 5 |
SW
Simplicity Wealth
Summit,
New Jersey
|
+$4.01M |
Top Sellers
| 1 | -$65.3M | |
| 2 | -$57.9M | |
| 3 | -$27.2M | |
| 4 |
YDMI
Y.D. More Investments
Ramat Gan,
Israel
|
-$17M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$16.3M |